Technical Analysis for HVO - Hvivo Plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Up | Strength | 0.00% | |
Shooting Star Candlestick | Bearish | 2.08% | |
Doji - Bearish? | Reversal | 2.08% | |
Gapped Down | Weakness | 2.08% | |
Down 3 Days in a Row | Weakness | 3.51% | |
Down 4 Days in a Row | Weakness | 3.51% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 2.61% | |
Down 3 Days in a Row | Weakness | 2.61% | |
New Uptrend | Bullish | 1.37% | |
Inside Day | Range Contraction | 0.34% |
Alert | Time |
---|---|
Down 1% | 1 day ago |
Gap Up Closed | 1 day ago |
Gap Up Partially Closed | 1 day ago |
Up 2% | 1 day ago |
10 DMA Support | 1 day ago |
Free Daily (Stock) Chart Reading
Hvivo Plc Description
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Disease Data Management Drug Development Infectious Disease Biomarker Asthma Malaria Cell Biology Copd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 32.0 |
52 Week Low | 12.4966 |
Average Volume | 4,025,352 |
200-Day Moving Average | 21.32 |
50-Day Moving Average | 27.78 |
20-Day Moving Average | 27.97 |
10-Day Moving Average | 29.00 |
Average True Range | 1.26 |
RSI (14) | 60.32 |
ADX | 30.31 |
+DI | 27.40 |
-DI | 10.82 |
Chandelier Exit (Long, 3 ATRs) | 28.22 |
Chandelier Exit (Short, 3 ATRs) | 28.28 |
Upper Bollinger Bands | 30.60 |
Lower Bollinger Band | 25.33 |
Percent B (%b) | 0.79 |
BandWidth | 18.83 |
MACD Line | 0.59 |
MACD Signal Line | 0.48 |
MACD Histogram | 0.1109 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 31.00 | ||||
Resistance 3 (R3) | 30.83 | 30.17 | 30.75 | ||
Resistance 2 (R2) | 30.17 | 29.78 | 30.25 | 30.67 | |
Resistance 1 (R1) | 29.83 | 29.55 | 30.00 | 30.00 | 30.58 |
Pivot Point | 29.17 | 29.17 | 29.25 | 29.25 | 29.17 |
Support 1 (S1) | 28.83 | 28.78 | 29.00 | 29.00 | 28.42 |
Support 2 (S2) | 28.17 | 28.55 | 28.25 | 28.33 | |
Support 3 (S3) | 27.83 | 28.17 | 28.25 | ||
Support 4 (S4) | 28.00 |